PMC:7102662 / 13899-14734 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T2","span":{"begin":490,"end":497},"obj":"https://glytoucan.org/Structures/Glycans/G15021LG"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T36","span":{"begin":401,"end":406},"obj":"Body_part"},{"id":"T37","span":{"begin":490,"end":497},"obj":"Body_part"},{"id":"T38","span":{"begin":597,"end":614},"obj":"Body_part"}],"attributes":[{"id":"A36","pred":"fma_id","subj":"T36","obj":"http://purl.org/sig/ont/fma/fma67264"},{"id":"A37","pred":"fma_id","subj":"T37","obj":"http://purl.org/sig/ont/fma/fma82743"},{"id":"A38","pred":"fma_id","subj":"T38","obj":"http://purl.org/sig/ont/fma/fma265130"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T17","span":{"begin":597,"end":614},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"uberon_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/UBERON_0000065"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T137","span":{"begin":0,"end":8},"obj":"Disease"},{"id":"T138","span":{"begin":218,"end":222},"obj":"Disease"},{"id":"T139","span":{"begin":234,"end":242},"obj":"Disease"},{"id":"T140","span":{"begin":285,"end":293},"obj":"Disease"},{"id":"T141","span":{"begin":356,"end":360},"obj":"Disease"},{"id":"T142","span":{"begin":597,"end":625},"obj":"Disease"},{"id":"T143","span":{"begin":705,"end":713},"obj":"Disease"}],"attributes":[{"id":"A137","pred":"mondo_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A140","pred":"mondo_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T93","span":{"begin":9,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T94","span":{"begin":26,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T19","span":{"begin":401,"end":406},"obj":"Chemical"},{"id":"T20","span":{"begin":490,"end":497},"obj":"Chemical"}],"attributes":[{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A21","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T44","span":{"begin":597,"end":625},"obj":"Phenotype"}],"attributes":[{"id":"A44","pred":"hp_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/HP_0011947"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T18","span":{"begin":401,"end":417},"obj":"http://purl.obolibrary.org/obo/GO_0006629"},{"id":"T19","span":{"begin":407,"end":417},"obj":"http://purl.obolibrary.org/obo/GO_0008152"},{"id":"T20","span":{"begin":490,"end":508},"obj":"http://purl.obolibrary.org/obo/GO_0006006"},{"id":"T21","span":{"begin":498,"end":508},"obj":"http://purl.obolibrary.org/obo/GO_0008152"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-sentences","denotations":[{"id":"T116","span":{"begin":0,"end":138},"obj":"Sentence"},{"id":"T117","span":{"begin":139,"end":296},"obj":"Sentence"},{"id":"T118","span":{"begin":297,"end":521},"obj":"Sentence"},{"id":"T119","span":{"begin":522,"end":631},"obj":"Sentence"},{"id":"T120","span":{"begin":632,"end":835},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T246","span":{"begin":0,"end":8},"obj":"SP_7"},{"id":"T247","span":{"begin":163,"end":171},"obj":"CHEBI:33695;CHEBI:33695;SO:0000673"},{"id":"T248","span":{"begin":218,"end":222},"obj":"SP_10"},{"id":"T249","span":{"begin":234,"end":242},"obj":"SP_10"},{"id":"T250","span":{"begin":285,"end":295},"obj":"SP_7"},{"id":"T251","span":{"begin":356,"end":360},"obj":"SP_10"},{"id":"T252","span":{"begin":401,"end":406},"obj":"CHEBI:18059;CHEBI:18059;GO:0006629"},{"id":"T253","span":{"begin":407,"end":417},"obj":"GO:0006629"},{"id":"T254","span":{"begin":490,"end":497},"obj":"CHEBI:17234;CHEBI:17234;GO:0006006"},{"id":"T255","span":{"begin":498,"end":508},"obj":"GO:0006006"},{"id":"T256","span":{"begin":597,"end":614},"obj":"UBERON:0000065"},{"id":"T257","span":{"begin":705,"end":713},"obj":"SP_7"},{"id":"T92815","span":{"begin":17,"end":32},"obj":"UBERON:0002037"},{"id":"T25744","span":{"begin":160,"end":164},"obj":"CL:0000037"},{"id":"T92830","span":{"begin":374,"end":382},"obj":"SP_7"},{"id":"T10783","span":{"begin":217,"end":225},"obj":"SP_7"},{"id":"T27416","span":{"begin":377,"end":382},"obj":"NCBITaxon:10239"},{"id":"T34190","span":{"begin":419,"end":424},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T90459","span":{"begin":424,"end":434},"obj":"NCBITaxon:11632"},{"id":"T6997","span":{"begin":435,"end":440},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T89731","span":{"begin":476,"end":483},"obj":"UBERON:0000948"},{"id":"T12959","span":{"begin":484,"end":489},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T37980","span":{"begin":576,"end":587},"obj":"CHEBI:3638;DG_10;CHEBI:3638"},{"id":"T83335","span":{"begin":588,"end":607},"obj":"CHEBI:5801;DG_20;CHEBI:5801"},{"id":"T32885","span":{"begin":612,"end":624},"obj":"CHEBI:2948;CHEBI:2948"},{"id":"T65115","span":{"begin":725,"end":730},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T66265","span":{"begin":820,"end":826},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"2_test","denotations":[{"id":"32247212-28831119-25241182","span":{"begin":517,"end":519},"obj":"28831119"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}

{"project":"LitCovid-PubTator","denotations":[{"id":"439","span":{"begin":99,"end":107},"obj":"Species"},{"id":"440","span":{"begin":234,"end":242},"obj":"Species"},{"id":"441","span":{"begin":285,"end":295},"obj":"Species"},{"id":"442","span":{"begin":324,"end":332},"obj":"Species"},{"id":"443","span":{"begin":566,"end":574},"obj":"Species"},{"id":"444","span":{"begin":810,"end":818},"obj":"Species"},{"id":"445","span":{"begin":0,"end":8},"obj":"Disease"},{"id":"446","span":{"begin":384,"end":417},"obj":"Disease"},{"id":"447","span":{"begin":441,"end":457},"obj":"Disease"},{"id":"448","span":{"begin":482,"end":508},"obj":"Disease"},{"id":"449","span":{"begin":597,"end":625},"obj":"Disease"},{"id":"450","span":{"begin":705,"end":713},"obj":"Disease"},{"id":"451","span":{"begin":831,"end":834},"obj":"Disease"}],"attributes":[{"id":"A439","pred":"tao:has_database_id","subj":"439","obj":"Tax:9606"},{"id":"A440","pred":"tao:has_database_id","subj":"440","obj":"Tax:694009"},{"id":"A441","pred":"tao:has_database_id","subj":"441","obj":"Tax:2697049"},{"id":"A442","pred":"tao:has_database_id","subj":"442","obj":"Tax:9606"},{"id":"A443","pred":"tao:has_database_id","subj":"443","obj":"Tax:9606"},{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"Tax:9606"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:C000657245"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:D052439"},{"id":"A447","pred":"tao:has_database_id","subj":"447","obj":"MESH:D018376"},{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"MESH:D044882"},{"id":"A449","pred":"tao:has_database_id","subj":"449","obj":"MESH:D012141"},{"id":"A450","pred":"tao:has_database_id","subj":"450","obj":"MESH:C000657245"},{"id":"A451","pred":"tao:has_database_id","subj":"451","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD."}